Working... Menu

The Effects of Periodontal Therapy on Glycemic Control in Diabetic Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03783845
Recruitment Status : Completed
First Posted : December 21, 2018
Last Update Posted : December 21, 2018
Information provided by (Responsible Party):
Yasser El Makaky, Taibah University

Brief Summary:
Is the non-surgical periodontal therapy can improve glycemic control in type 2 diabetic patients with chronic periodontitis?

Condition or disease Intervention/treatment Phase
Chronic Periodontitis, Generalized Drug: amoxicillin and metronidazole Phase 4

Detailed Description:

The aim of the present study was to monitor the clinical outcomes and the metabolic response of non-surgical periodontal therapy in patients with chronic periodontitis and uncontrolled type 2 diabetes.

Regarding clinical and metabolic parameters at baseline, no differences were displayed between two groups. However, at 3-months follow-up period the patients within a test group were demonstrated better clinical outcomes than patients in a control group

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 44 participants
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Single (Participant)
Primary Purpose: Treatment
Official Title: The Effects of Non -Surgical Periodontal Therapy on Glycemic Control and Periodontal Health in Diabetic Patients With Periodontitis (Randomized Controlled Clinical Trial)
Actual Study Start Date : June 1, 2015
Actual Primary Completion Date : March 1, 2016
Actual Study Completion Date : March 30, 2016

Arm Intervention/treatment
Experimental: test group
. metronidazole 400mg,three times daily for two weeks. amoxicillin 500mg,three times daily for two weeks.
Drug: amoxicillin and metronidazole
metronidazole 400mg and amoxicillin 500mg three times daily for two weeks
Other Name: Amoxil and Flagyl

No Intervention: control group
no intervention during study period

Primary Outcome Measures :
  1. glycosylated haemoglobin (HbA1c) [ Time Frame: 3 months ]
    Blood was taken from a peripheral vein to monitor HbA1c using high-performance liquid chromatography

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   40 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

Diagnosis of diabetes type 2 for more than five years Type 2 diabetes with HbA1c level from 7% to 9% at the last medical evaluation Diagnosis with chronic periodontitis

Exclusion Criteria:


  • Alcoholism and smoking
  • Presence of any systemic disorders other than hypertension and diabetes
  • Diabetic major complications
  Study Documents (Full-Text)

Documents provided by Yasser El Makaky, Taibah University:

Layout table for additonal information
Responsible Party: Yasser El Makaky, Associated professor, Taibah University Identifier: NCT03783845     History of Changes
Other Study ID Numbers: periodontal therapy and HbA1c
First Posted: December 21, 2018    Key Record Dates
Last Update Posted: December 21, 2018
Last Verified: December 2018

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Layout table for MeSH terms
Chronic Periodontitis
Periodontal Diseases
Mouth Diseases
Stomatognathic Diseases
Anti-Bacterial Agents
Anti-Infective Agents
Antiprotozoal Agents
Antiparasitic Agents